Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis.

MLA

Deguchi, Takashi, et al. “Macrolide and Fluoroquinolone Resistance Is Uncommon in Clinical Strains of Chlamydia Trachomatis.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, vol. 24, no. 8, Aug. 2018, pp. 610–14. EBSCOhost, https://doi.org/10.1016/j.jiac.2018.03.007.

APA

Deguchi, T., Hatazaki, K., Ito, S., Kondo, H., Horie, K., Nakane, K., Mizutani, K., Tsuchiya, T., Yasuda, M., Yokoi, S., & Nakano, M. (2018). Macrolide and fluoroquinolone resistance is uncommon in clinical strains of Chlamydia trachomatis. Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy, 24(8), 610–614. https://doi.org/10.1016/j.jiac.2018.03.007

Chicago

Deguchi, Takashi, Kyoko Hatazaki, Shin Ito, Hiromi Kondo, Kengo Horie, Keita Nakane, Kosuke Mizutani, et al. 2018. “Macrolide and Fluoroquinolone Resistance Is Uncommon in Clinical Strains of Chlamydia Trachomatis.” Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy 24 (8): 610–14. doi:10.1016/j.jiac.2018.03.007.